Taking part in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.

This study will admit a wide range of data on the clinical trial experience of Alzheimer's Disease patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Alzheimer's Disease patients.

Inclusion Criteria:

• Patient is at least 50 to 80 years of age
• Participant has a diagnosis of Alzheimer's Disease
• Patient has self-identified as planning to enroll in an interventional clinical trial for Alzheimer's Disease

Exclusion Criteria:

• No diagnosis of Alzheimer's Disease confirmed
• Inability to perform regular electronic reporting
• Patient does not understand, sign, and return consent form

Alzheimer's Disease patients who are actively considering involvement in an interventional clinical trial, but have not yet completed enrollment and registration.